Ruben A. Mesa, MD of Mayo Clinic discusses questions from the audience that were asked during his session on the new guidelines for myeloproliferative neoplasms. He states that overall quality has become the main focus for these guidelines. This was recorded at 2017 National Comprehensive Cancer Network (NCCN) Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care in Orlando, Florida.
Quality Benchmarks Focus for New Myeloproliferative Neoplasms Guidelines
